Qunwei L. Xu
Nanjing, 211166, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Tailor-made legumain/pH dual-responsive doxorubicin prodrug-embedded nanoparticles for efficient anticancer drug delivery and in situ monitoring of drug release.
Journal: Nanoscale
Published: January 17, 2020
Programmed co-delivery of platinum nanodrugs and gemcitabine by a clustered nanocarrier for precision chemotherapy for NSCLC tumors.
Journal: Journal of materials chemistry. B
Published: December 12, 2019
Bioengineered Boronic Ester Modified Dextran Polymer Nanoparticles as Reactive Oxygen Species Responsive Nanocarrier for Ischemic Stroke Treatment.
Journal: ACS nano
Published: June 06, 2018
Differential expression of miR16 in glioblastoma and glioblastoma stem cells: their correlation with proliferation, differentiation, metastasis and prognosis.
Journal: Oncogene
Published: December 04, 2016
Enhanced Antiglioblastoma Efficacy of Neovasculature and Glioma Cells Dual Targeted Nanoparticles.
Journal: Molecular pharmaceutics
Published: September 17, 2016
PEGylated Polyamidoamine dendrimer conjugated with tumor homing peptide as a potential targeted delivery system for glioma.
Journal: Colloids and surfaces. B, Biointerfaces
Published: June 14, 2016
Dual targeted nanocarrier for brain ischemic stroke treatment.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: February 21, 2016
Improved anti-glioblastoma efficacy by IL-13Rα2 mediated copolymer nanoparticles loaded with paclitaxel.
Journal: Scientific reports
Published: August 10, 2015
Enhanced anti-ischemic stroke of ZL006 by T7-conjugated PEGylated liposomes drug delivery system.
Journal: Scientific reports
Published: March 30, 2015
The inhibition effect of expressions of miR-221 and miR-222 on glioma and corresponding mechanism.
Journal: Bratislavske lekarske listy
Published: November 28, 2014
Methazolamide-loaded solid lipid nanoparticles modified with low-molecular weight chitosan for the treatment of glaucoma: vitro and vivo study.
Journal: Journal of drug targeting
Published: July 22, 2014
Last Updated: 09/26/2026